ProCE Banner Activity


Delivering High-Quality IBD Care to South Asian


South Asian gastroenterologists and a South Asian registered dietitian provide healthcare professionals’ perspectives from India and the United States on the unique challenges and cultural barriers to IBD care that affect South Asian patients.

Physician Assistants/Physician Associates: 0.50 AAPA Category 1 CME credit

Nurses: 0.50 Nursing contact hour

Physicians: Maximum of 0.50 AMA PRA Category 1 Credit

Released: July 14, 2023

Expiration: July 13, 2024

No longer available for credit.



Tauseef Ali

Tauseef Ali, MD, FACG, AGAF

Medical Executive Director
SSM Health Crohn’s and Colitis Center
Oklahoma City, Oklahoma

Tina Aswani-Omprakash

Tina Aswani-Omprakash, MPH

President and Co-Founder, South Asian IBD Alliance
Mount Sinai Department of Medicine
Dr. Henry D. Janowitz Division of Gastroenterology
New York, New York

Sumit Bhatia

Sumit Bhatia, MBBS, MD, DM

Senior Consultant 
Gastroenterology and Hepatology 
Paras Hospitals 
Gurgaon, Haryana, India 

Parakkal Deepak

Parakkal Deepak, MBBS, MS, FACG 

Vice-President, South Asian IBD Alliance
Director of Clinical and Translational Research
Associate Professor of Medicine 
Division of Gastroenterology
John T. Milliken Department of Medicine 
Washington University School of Medicine in St. Louis 
St. Louis, MO, USA

Neil Nandi

Neil Nandi, MD, FACP

Associate Professor Of Clinical Medicine
Division of Gastroenterology and Hepatology
University of Pennsylvania, Perelman School Of Medicine
Philadelphia, Pennsylvania

Neha D. Shah

Neha D. Shah, MPH, RD, CNSC, CHES

Senior Dietitian 
Colitis and Crohn's Disease Center 
University of California, San Francisco 
San Francisco, California 

Provided by

Provided by Clinical Care Options, LLC in partnership with the South Asian IBD Alliance.

ProCE Banner
ProCE Banner


This activity is supported by independent educational grants from Takeda Pharmaceuticals U.S.A., Inc,  Janssen Pharmaceutical Companies, Lilly, Bristol-Myers Squibb (BMS), and Hollister, Inc.

Bristol Myers Squibb

Hollister, Inc.

Janssen Pharmaceutical Companies


Takeda Pharmaceuticals U.S.A., Inc.

Target Audience

The enduring activities are intended for US- and OUS-based gastroenterologists, gastroenterology nurse practitioners and physician associates/physician assistants, primary care providers, and other healthcare professionals treating patients with IBD.

Program Learning Goal

The goal of this activity is to improve the clinical knowledge and competence among gastroenterology HCPs regarding the culturally sensitive management of South Asian patients with IBD.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Detail the cultural influences for South Asian patients on their perspectives of IBD


Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:

Tauseef Ali, MD, FACG, AGAF: consultant/advisor/speaker: AbbVie, Bristol Myers Squibb, Janssen, Takeda. 

Tina Aswani-Omprakash, MPH: consultant/advisor/speaker: AbbVie, Boehringer Ingelheim, Genentech/Roche, Hollister, Janssen, Pfizer, Takeda, Tillotts.

Sumit Bhatia, MBBS, MD, DM: consultant/advisor/speaker: Dr. Reddy’s, Ferring, Janssen India, MSN, Takeda India, Zydus.

Parakkal Deepak, MBBS, MS, FACG: consultant/advisor/speaker: AbbVie, Bristol Myers Squibb/Celgene, Fresenius, Kabi; researcher: AbbVie, Alimentiv, Boehringer Ingelheim, Bristol Myers Squibb/Celgene, CorEvitas, Genentech Roche, Iterative Scopes, Janssen, Pfizer/Arena, Prometheus, Scipher, Takeda.

Neilanjan Nandi, MD, FACP: consultant/advisor/speaker: AbbVie, Boehringer Ingelheim, Bristol Myers Squibb, Janssen, Pfizer.

Neha D. Shah, MPH, RD, CNSC, CHES, has no relevant financial relationships to disclose.

The planners and content peer reviewers from Clinical Care Options, LLC and South Asian IBD Alliance do not have any relevant financial relationships to disclose.

Instructions for Credit

Participation in this self-study activity should be completed in approximately 0.5 hour. To successfully complete this activity and receive credit, learners must follow these steps during the period from July 14, 2023, through July 13, 2024:

 1. Login or Sign Up for an account by clicking at the top of this page.

2. Read the target audience, learning objectives, and faculty disclosures.

3. View and study the content in its entirety.

4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 65% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the confirmation page. Records of all CME/CE activities completed can be found on the "My Certificates" page. There are no costs/fees for this activity.


This program has been made available online.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.


Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.


Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Clinical Care Options, LLC (CCO) and the South Asian IBD Alliance. Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

CCO designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 0.5 contact hours.

Physician Assistant/Physician Associate Continuing Medical Education

Clinical Care Options, LLC has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.5 AAPA Category 1 CME credits. Approval is valid until July 13, 2024. PAs should only claim commensurate with the extent of their participation.